Archive - August 2019
Sunovion Announces Acceptance by the U.S. FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Humana lawsuit targets Mallinckrodt’s ‘billion-dollar golden goose’
Reason Why You Should Avoid Areas Surrounded By Fast Food
Odd But True: Intense Light Protects Cardiovascular Health